Aurobindo bags one more cephalosporin from USFDA

16108 Investors following Aurobindo Pharm. Share this News with them.

0

Like this story, share it with millions of investors on M3

Aurobindo bags one more cephalosporin from USFDA

Aurobindo bags one more cephalosporin from USFDA

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS 3 more European buys for Aurobindo Pharma Aurobindo Pharma buys Dutch firm Pharmacin Aurobindo receives approval of Efavirenz Aurobindo Pharma can easily go upto Rs 750 ALSO READ See latest News about Aurobindo Pharm See previous management interviews See what other Experts & Brokerages are saying about Aurobindo Pharm Aurobindo Pharm BSE | NSE 25/05/12 Are Mutual Funds betting on Aurobindo Pharm?

Aurobindo Pharma is pleased to announce that the company has received one more approval from USFDA for Cefadroxil capsules 500mg. Cefadroxil is a first generation Cephalosporin antibiotic. It is used in a wide variety of bacterial infections (respiratory, skin & soft tissue, and Urinary tract infections).

Cefadroxil is Aurobindo's 37th USFDA approval in total and third approval from its cephalosporin range.

Cefadroxil 500mg capsules commands a market of over 21 mio dollars in the USA.

Sourced From: Aurobindo Pharma Limited